Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: Possible role in AP-1-mediated proliferation of ER-negative endometrial cancer

Gynecologic Oncology

Volumn 81, Issue 3, 2001, Pages 366-372

  Fournier, David B ^a   Chisamore, Michael ^a   Lurain, John R ^a   Rademaker, Alfred W ^a   Jordan, V Craig ^a   Tonetti, Debra A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Endometrial cancer; Estrogen receptor; Prognostic factors; Protein kinase c; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; TAMOXIFEN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER SIZE; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UTERUS; WESTERN BLOTTING;

EID: 0034980135     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6164     Document Type: Article

References (38)

1. Cancer statistics, 2000
2. Uterine cancer
3. Targeted anti-estrogens to treat and prevent diseases in women
4. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
5. Possible mechanisms in the emergence of tamoxifen-resistant breast cancer
6. The role of estrogen receptor mutations in tamoxifen-stimulated breast cancer
7. Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: Involvement of the estrogen receptor
8. Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance
9. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity
10. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
11. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
12. Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines
13. The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation
14. New insights into the regulation of protein kinase C and novel phorbol ester receptors
15. Protein kinase C - A question of specificity
16. Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: Possible quantitative relationship
17. Immunological quantitation of phospholipid/Ca2+-dependent protein kinase of human mammary carcinoma cells: Inverse relationships to estrogen receptors
18. Antiestrogen stimulated human endometrial cancer growth: Laboratory and clinical considerations
19. Protein kinase C (PKC) isoenzyme expression pattern as an indicator of proliferative activity in uterine tumor cells
20. Clinical implication of fos and jun expressions and protein kinase activity in endometrial cancers
21. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation
22. Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer
23. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium
24. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma
25. Modulation of estrogen receptor levels in mouse uterus by protein kinase C isoenzymes
26. Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate
27. Isolation of protein kinase C-a-regulated cDNAs associated with breast tumor aggressiveness by differential mRNA display [in process citation]
28. Protein kinase C and its isoforms in human breast cancer cells: Relationship to the invasive phenotype
29. PKCalpha regulates betal integrin-dependent cell motility through association and control of integrin traffic
30. Overexpression of protein kinase Calpha in MCF-10A human breast cells engenders dramatic alterations in morphology, proliferation, and motility
31. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype
32. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
33. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
34. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
35. Husseinzadeh N. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue
36. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions